No black box warning on record for Femmepap
As of the latest FDA labeling reviewed, Femmepap (THUJA OCCIDENTALIS, NITRICUM ACIDUM, CAUSTICUM, SABINA, ANTIMONIUM SULPHURATUM RUBRUM, HUMAN PAPILLOMA NOSODE, X-RAY, ADENOVIREN NOSODE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Femmepap medicine page for the complete safety profile.